Phạm, Thành Luân, et al. “RESULT OF PEMBROLIZUMAB PLUS CHEMOTHERAPY IN THE FIRST-LINE THERAPY FOR DISTANT METASTATIC NON-SMALL-CELL LUNG CANCER WITH PD-L1 ≥1%, EGFR(-), ALK(-) AND ROS1(-)”. Journal of 175 Practical Medicine and Pharmacy, no. 37, Mar. 2024, p. 13, doi:10.59354/ydth175.2024.240.